Calla Lily Clinical Care is a Certified B-Corporation, formed in 2021 out of Callaly, one of Fast Company’s Most Innovative Companies of 2021. B-Corps are a growing global group of organisations committed to using business as a force for good. The company is committed towards meeting the highest standards of social and environmental performance, accountability and transparency. We’re excited about the prospects of our more cost-effective, comfortable and accessible women’s drug-delivery device manufactured with a more sustainable footprint.
Team
Thang Vo-Ta
CEO & Co-founder
Dr Lara Zibners Lohr
Co-founder
Prof Andrew Lewis
Principal Scientist
Ewa Radziwon
Product Development Manager
Stuart Prince
Chief Financial Officer
Akeel Khan
Chief Product Officer
Dr Yasmin Farhatnia
R&D Manager
Dr Serena de Gelidi
Senior Biomechanical Engineer
Dr Elham Shirani
Biomedical Engineer
Kaylie Mings
Product Development
Dr Arturo Jose Mendoza Meinhardt
Senior Scientist
Sabrina Franco
Product Development Engineer
Megan Quinlan
Legal & Strategy
Shaun Knights
Head of Regulatory & Quality
Clinical & scientific advisors
Prof Siobhan Quenby
Board Advisor / Clinical Expert – Miscarriage
Dr Stuart Lavery
Board Advisor / Clinical Expert – Fertility
Dr Annalisa Jenkins
Board Advisor
Dr Kelle Moley
Board Advisor
Dr Janet Halliday
Board Advisor – CMC
Dr Alex Hooi
Board Advisor / Inventor
We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.